Atlas FDA

INFINION CX LEAD KIT, 50CM, Model: SC-2317-50, Material: M365SC2317500; INFINION CX LEAD KIT, 70CM, Model: SC-2317-70, M

FDA device recall Z-2879-2026 · posted 2026-08-05 · Open, Classified

Recall details

Recalling firm
Boston Scientific Neuromodulation Corporation
Reason for recall
Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.
Action taken
On 6/17/2026, removal notices were mailed and emailed to customers informing them of the following: 1) Stop further use or distribution and segregate affected product. 2) Complete and return the Reply Verification Tracking Form via email to BSCFieldActionCenter@bsci.com 3) Return affected devices to firm. 4) Share this communication with any healthcare professionals in your facility that use the product and with any other organization to which these systems may have been transferred. Report any adverse events or quality concerns associated with use of these devices to firm via email at BSCComplaints@bsci.com This removal of unused Infinion CX Leads is part of the planned transition to the next generation lead (Infinion Pro).
Root cause
Device Design
Status
Open, Classified
Product code
LGW
Quantity affected
1079
Distribution
US: NY. OUS: Canada, Portugal, Spain, France, Netherlands, Great Britain, Italy, Israel, Serbia, Greece, Germany, United Arab Emirates, Ireland, Hungary, Czech Republic, Brazil, Colombia, Argentina
Date initiated
2026-06-17
Date posted
2026-08-05
Location
Valencia, CA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.